1-21570394-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000478.6(ALPL):​c.862+20G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.144 in 1,611,926 control chromosomes in the GnomAD database, including 21,827 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 3131 hom., cov: 33)
Exomes 𝑓: 0.14 ( 18696 hom. )

Consequence

ALPL
NM_000478.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.772

Publications

13 publications found
Variant links:
Genes affected
ALPL (HGNC:438): (alkaline phosphatase, biomineralization associated) This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects. [provided by RefSeq, Oct 2015]
ALPL Gene-Disease associations (from GenCC):
  • adult hypophosphatasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • ALPL-related autosomal dominant hypophosphatasia
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood hypophosphatasia
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Orphanet
  • ALPL-related autosomal recessive hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
  • infantile hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • odontohypophosphatasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • perinatal lethal hypophosphatasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-21570394-G-T is Benign according to our data. Variant chr1-21570394-G-T is described in ClinVar as Benign. ClinVar VariationId is 256233.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.438 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000478.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALPL
NM_000478.6
MANE Select
c.862+20G>T
intron
N/ANP_000469.3
ALPL
NM_001369803.2
c.862+20G>T
intron
N/ANP_001356732.1P05186-1
ALPL
NM_001369804.2
c.862+20G>T
intron
N/ANP_001356733.1P05186-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALPL
ENST00000374840.8
TSL:1 MANE Select
c.862+20G>T
intron
N/AENSP00000363973.3P05186-1
ALPL
ENST00000374832.5
TSL:2
c.862+20G>T
intron
N/AENSP00000363965.1P05186-1
ALPL
ENST00000879459.1
c.742+20G>T
intron
N/AENSP00000549518.1

Frequencies

GnomAD3 genomes
AF:
0.183
AC:
27822
AN:
151946
Hom.:
3118
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.252
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.224
Gnomad ASJ
AF:
0.142
Gnomad EAS
AF:
0.452
Gnomad SAS
AF:
0.234
Gnomad FIN
AF:
0.187
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.111
Gnomad OTH
AF:
0.178
GnomAD2 exomes
AF:
0.183
AC:
45705
AN:
250058
AF XY:
0.178
show subpopulations
Gnomad AFR exome
AF:
0.255
Gnomad AMR exome
AF:
0.250
Gnomad ASJ exome
AF:
0.139
Gnomad EAS exome
AF:
0.442
Gnomad FIN exome
AF:
0.183
Gnomad NFE exome
AF:
0.107
Gnomad OTH exome
AF:
0.156
GnomAD4 exome
AF:
0.140
AC:
204817
AN:
1459862
Hom.:
18696
Cov.:
32
AF XY:
0.141
AC XY:
102701
AN XY:
726352
show subpopulations
African (AFR)
AF:
0.265
AC:
8860
AN:
33424
American (AMR)
AF:
0.245
AC:
10946
AN:
44590
Ashkenazi Jewish (ASJ)
AF:
0.140
AC:
3657
AN:
26112
East Asian (EAS)
AF:
0.511
AC:
20247
AN:
39656
South Asian (SAS)
AF:
0.217
AC:
18678
AN:
86156
European-Finnish (FIN)
AF:
0.175
AC:
9337
AN:
53254
Middle Eastern (MID)
AF:
0.131
AC:
752
AN:
5758
European-Non Finnish (NFE)
AF:
0.111
AC:
123005
AN:
1110584
Other (OTH)
AF:
0.155
AC:
9335
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
8275
16550
24824
33099
41374
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4962
9924
14886
19848
24810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.183
AC:
27873
AN:
152064
Hom.:
3131
Cov.:
33
AF XY:
0.191
AC XY:
14174
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.252
AC:
10449
AN:
41502
American (AMR)
AF:
0.225
AC:
3433
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.142
AC:
494
AN:
3472
East Asian (EAS)
AF:
0.454
AC:
2328
AN:
5130
South Asian (SAS)
AF:
0.234
AC:
1128
AN:
4820
European-Finnish (FIN)
AF:
0.187
AC:
1983
AN:
10580
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.111
AC:
7534
AN:
67978
Other (OTH)
AF:
0.182
AC:
384
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1108
2216
3325
4433
5541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.145
Hom.:
358
Bravo
AF:
0.191
Asia WGS
AF:
0.327
AC:
1137
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
not provided (2)
-
-
1
Adult hypophosphatasia (1)
-
-
1
Childhood hypophosphatasia (1)
-
-
1
Hypophosphatasia (1)
-
-
1
Infantile hypophosphatasia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.2
DANN
Benign
0.65
PhyloP100
-0.77
PromoterAI
-0.049
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2275377; hg19: chr1-21896887; COSMIC: COSV66376057; COSMIC: COSV66376057; API